The Impact of Azadirachta Indica Extract on the Expression Profile of Esp Gene in Treated Enterococcus faecalis
RESEARCH ARTICLE

The Impact of Azadirachta Indica Extract on the Expression Profile of Esp Gene in Treated Enterococcus faecalis

Niaz Hamaghareeb Hamasaeed1 , * Open Modal
Authors Info & Affiliations
The Open Dentistry Journal 24 Jun 2024 RESEARCH ARTICLE DOI: 10.2174/0118742106293218240516052549

Abstract

Background and Objectives

Enterococcus faecalis is a bacterium often associated with persistent endodontic infections, posing challenges for effective root canal disinfection and treatment outcomes due to its resilience in adverse root canal conditions and resistance to antimicrobial therapies. This study aimed to investigate the effects of Azadirachtaindica's active plant compounds at subinhibitory concentrations on the expression of the virulence gene (esp) in Enterococcus faecalis strains (ATCC 29212).

Materials and Methods

Azadirachta indica (neem) specimens were obtained in Erbil, Northern Iraq, and the active compounds from the dried plant samples were extracted. Dry extracts were dissolved in Dimethylsulphoxide (DMSO) until reaching 100 mg/ml. Bacterial samples were treated with the extracted plant material and incubated. The assessment of relative esp gene expression in treated Enterococcus faecalis strains (ATCC 29212) began with total RNA extraction using the RNXplus kit, followed by a Quantitative RT-PCR assay.

Results

The minimum concentration of Azadirachta indica's ethyl acetate fraction 3 (30 mg/ml) inhibited the growth of the targeted bacteria. In contrast, the highest concentration inhibiting the target bacteria was 50 mg/ml of fraction 6 (Azadirachta indica-water). All fractions of Azadirachta indica decreased the expression of the target gene, with fraction 5 (ethyl alcohol) showing the highest fold change.

Conclusion

The ethyl alcohol extraction of Azadirachta indica inhibited the expression of the virulence gene (esp) by 2.84-fold, suggesting a potential decrease in (esp) gene expression, which could be considered as an alternative to classical irrigants.

Keywords: Enterococcus faecalis, Endodontic, Esp gene, Fractions, Infection, Plant.

1. INTRODUCTION

The main reason for the failure of teeth treated with endodontics is the prolonged inflammatory response within the intricate root canal system [1, 2]. This inflammatory cascade ensues when recalcitrant bacteria from the initial infection withstand the exigencies of chemo-mechanical treatment or when a novel, transmissible pathogen emerges, either intraoperatively or postoperatively [3-5].

Enterococci, prevalent in the oral cavity, gastrointestinal tract, and vagina of humans and animals, were once considered nonvirulent but are now acknowledged as significant contributors to nosocomial infections worldwide [6, 7]. Enterococci, Gram-positive cocci found singly, in pairs, or in short chains, are facultative anaerobes that can grow with or without oxygen [8, 9]. Enterococcus, a prominent contributor to endodontic infections, is recognized for its resilience in diverse environmental conditions [10-12]. Furthermore, its survival mechanisms involve genetic variations and the ability to attach to dentin, penetrate dentinal tubules, and withstand periods of starvation [13, 14]. Another study enables us to speculate about a connection between enamel permeability, susceptibility to cavities, and the failure of adhesive bonds in primary teeth [15].

In endodontics, particularly Enterococcus faecalis, is linked to chronic periodontitis and unsuccessful root canal treatments involving chronic apical periodontitis [16-18]. Enterococcus faecalis intricately links to primary, secondary, and persistent infections associated with periradicular disease [19-21]. Notably, Enterococcus faecalis predominantly surface in secondary endodontic infections, with its prevalence ranging from 30% to 90% [22]. These infections typically manifest in previously filled root canals. In such instances, Enterococcus faecalis exhibits a remarkable capacity to form biofilms, thereby exacerbating the complexities of infection resolution [23]. Bacteria deploy virulence factors to invade and persist in the host during infections [24]. Cytolysin, a toxin from Enterococcus faecalis, directly lyses host cells, intensifying bacterial virulence [25]. Gelatinase contributes to pathogenesis by hydrolyzing various host proteins and aiding in adhesion to dentin [26, 27]. Hyaluronidase promotes tissue destruction by breaking down hyaluronic acid [28]. Aggregation Substance (AS) enhances bacterial resistance to macrophages and facilitates adhesion to host cells [29, 30]. Enterococcal surface protein (esp) is linked to infective endocarditis and biofilm formation, impacting E. faecalis virulence [31]. The Enterococcal surface protein (Esp) is a substantial, 1873-amino-acid, Bap-orthologous protein with distinct modules. These include the N-terminal domain (26% sequence identity with Bap), the central core region with domains A and B (23% sequence identity with C-repeats of Bap), and the C-terminal domain containing the LPXTG-like motif found in surface-associated proteins. Esp is integral to biofilm formation by E. faecalis, with its N-terminal domain identified as the minimal region enhancing this process [32]. A comprehensive understanding of the prevalence and pathogenicity of Enterococcus faecalis in these endodontic scenarios is essential for formulating precise and customized therapeutic strategies to address the challenges posed by persistent infections within the root canal system [33]. Biochemical and structural studies revealed that the ~75 kDa N-terminal region of Esp enhances enterococcal biofilms against disruption, particularly under low pH conditions (≤ 4.3), forming an amyloid-like structure. A ~20 kDa fragment, EspDDDK, derived from the very N-terminus, is sufficient for biofilm strengthening at pH ≤ 5.0, suggesting Esp's role in reinforcing biofilms in acidic environments [34].

In the realm of endodontic disinfection, multiple options are available, each with its unique set of advantages and drawbacks [35, 36]. Sodium hypochlorite (NaOCl) stands out as a potent disinfectant effective against a broad spectrum of bacteria, including Enterococcus faecalis, and possesses the ability to dissolve tissues [37] readily. However, its application is not without challenges, as it exhibits cytotoxicity, can cause tissue burns, imparts an unpleasant taste and odor, and has the potential to stain the patient's clothing [38].

On a contrasting note, chlorhexidine has demonstrated notable efficacy in disinfection [39, 40]. Yet, being a synthetic compound, it has been reported to be toxic to various cell types, including fibroblasts, Polymor- phonuclear leukocytes (PMNs), other leukocytes, macrophages, and erythrocytes [41]. To explore alternative methods, diode laser irradiation has emerged as an additional antibacterial disinfection approach in dentistry. However, it is crucial to underline that further research is imperative to confirm the biological safety of employing diode lasers in this context [42].

Due to the increasing worry about antibiotic resistance stemming from excessive usage, it's prudent to exercise caution when prescribing them. Many endodontic infections, which are typically confined within the tooth, can be efficiently addressed through established local treatment methods [40]. Consequently, for conditions such as symptomatic irreversible pulpitis, pulp necrosis, symptomatic apical periodontitis, chronic apical abscess, and acute apical abscess without systemic complications, it is advisable to refrain from the unnecessary administration of additional systemic antibiotics alongside standard endodontic procedures [43]. This sophisticated methodology underscores the significance of customizing therapeutic interventions based on distinct clinical contexts, thereby optimizing the balance between efficacy and patient safety [44, 45].

Diverse irrigants have been enlisted for the management of endodontic infections [46]. Presently, there is a discernible inclination towards contemporary methodologies that prioritize natural remedies over conventional bactericidal medications [46]. Azadirachta indica (A. indica), colloquially known as neem and belonging to the Meliaceae botanical family, has garnered significant attention in this regard, owing to its rich repository of medicinal compounds [47-49]. Traditionally employed in medicinal practices, various components of A. indica, including leaves, bark, and seeds, manifest notable antibacterial and antifungal properties against a spectrum of harmful microorganisms. Furthermore, these components exhibit antiviral effects against vaccinia, chikungunya, measles, and Coxsackie B viruses [50].

The pharmacological prowess of Neem extends beyond its antimicrobial attributes, encompassing a diverse array of therapeutic effects [51]. Notably, its antioxidant [52], antimalarial [53], antimutagenic [54], anticarcinogenic [55, 56], anti-inflammatory [57], antihyperglycemic [58], antiulcer [57, 59], and anti-diabetic capabilities have been extensively demonstrated across various segments of the plant [60, 61], including the leaf, bark, and seeds [62]. Thus, Neem has multiple medicinal qualities that can be useful in endodontic therapy, providing not just protection against microbes but also offering additional therapeutic effects.

The objective of this study was to explore the impact of subinhibitory concentrations of active compounds derived from the neem plant on the expression of the virulence gene (esp) in strains of Enterococcus faecalis (ATCC 29212). The research aimed to examine and understand the effects of these specific neem-derived compounds at concentrations that do not completely inhibit bacterial growth but may still influence the expression of virulence genes in the targeted E. faecalis strains.

2. MATERIALS AND METHODS

2.1. Samples

The process of creating plant extracts involves several crucial steps, including collecting plant material, grinding it to the desired consistency, weighing the plant material, evaporating solvents, filtering the remnants, and calculating the yield percentage. The selection of solvents for extraction was based on the polarity of the solute used in this study, ranging from low to high polarity: Chloroform, Butanol, Ethylacetate, Hexane, Ethanol, and Water. All solvents used in the extraction process served as blanks and controlled in every trial throughout the investigation to entirelysolvent-related influences entirely. For the extraction of plant samples (Azadirachta indica) (50g), a mixture with hexane (100ml) was incubated for 1.5 hours at 37°C. The resultant mixture was filtered to obtain the first extract part (fraction 1), and the solvent was removed using a rotary evaporator. The remaining material was then air-dried at room temperature and used for subsequent solvent extractions. The same method, as employed for other solvents, was used to obtain various extract fractions (fraction 2 from chloroform, fraction 3 from ethylacetate, fraction 4 from butanol, fraction 5 from ethanol, and fraction 6 from water). Dry extracts were dissolved in Dimethylsulphoxide (DMSO) to reach a concentration of 100 mg/ml. The active compounds extracted were utilized in the treatment of Enterococcus faecalis (ATCC 29212), sourced from the Media Center in Erbil, Iraq. Bacterial samples were streaked onto two BHI agar plates (Scharlau Chemie S.A., Barcelona, Spain) and incubated for 24 hours at 37°C. Subsequently, purity was assessed through Gram staining and the examination of colony morphology [63].

2.2. Bacteriology

The process of determining the Minimum Inhibitory Concentration (MIC) was initiated by preparing stock solutions in sterile microcentrifuge tubes provided by Eppendorf. In order to assess the antibacterial effectiveness, a series of dilutions spanning a concentration range from 5 to 100 mg/ml were executed in 96-well microplates. The activation of bacterial suspensions involved achieving a concentration of 1.5 x 10^8 CFU/ml, equivalent to 0.5 on the MacFarland scale, through the utilization of Müeller-Hinton broth. Subsequently, each well of the microplate was inoculated with 10 ml of the reactivated bacterial suspension, and the entire plate was then incubated at 37 °C for a duration of 24 hours to facilitate optimal bacterial growth. This comprehensive methodology ensured a systematic evaluation of the antimicrobial properties across varying concentrations of the neem-derived compounds.

2.3. RNA Extraction, Quality Assessment, and RT-PCR Analysis

RNA extraction was performed on both treated and untreated Enterococcus faecalis (ATCC 29,212) samples, harvested at 37°C for 24 hours, utilizing the RNXplus kit. The RNA was extracted from 60 treated samples (10 samples per fraction) and 10 untreated samples. Following extraction, the quality of the RNA was verified using Nanodrop. After purification, gene expression was evaluated through Reverse Transcription-Polymerase Chain Reaction (RT-PCR). This comprehensive approach ensured the thorough analysis of RNA from diverse treated and untreated samples, providing valuable insights into gene expression patterns. This gene expression analysis involved the use of specific primers and a one-step quantitative RT-PCR kit, as detailed in Tables 1 and 2. A comparative critical threshold real-time PCR method was employed to gauge the impact of plant extracts on the gene of interest. It's noteworthy that all experimental calculations were meticulously executed twice to ensure the reliability and consistency of the results.

Table 1.
Composition of the overall reaction mixture.
Component Volume (μl)
Primers (F and R) 1 each
2X Reaction Buffer 2
Enzyme Solution 1
RNA Extract 3
Nuclease-free wate 12
TOTAL 20
Table 2.
RT-PCR procedure steps and parameters.
Step Temperature (°C) Time
cDNA Synthesis at 50°C 50 20 minutes
Initial Activation Phase 94 5 minutes
Denaturation (40 cycles) 94 25 seconds
Annealing (40 cycles) 63 60 seconds
Extension (40 cycles) 68 60 seconds

Table 1 details the precise composition of the comprehensive reaction mixture employed in the gene expression analysis through reverse transcription-polymerase chain reaction (RT-PCR). The table provides specific volumes for components, including primers, 2X reaction buffer, enzyme solution, RNA extract, and nuclease-free water, totaling 20 μl.

In Table 2, the RT-PCR procedure steps and parameters are succinctly outlined. The cDNA synthesis occurs at 50°C for 20 minutes, followed by an initial activation phase at 94°C for 5 minutes. The denaturation step, consisting of 40 cycles, operates at 94°C for 25 seconds, while the annealing step at 63°C lasts for 60 seconds during each cycle. Finally, the extension step, also comprising 40 cycles, occurs at 68°C for 60 seconds per cycle. These procedural details provide a comprehensive guide for conducting the RT-PCR experiment.

2.4. Ethics

The corresponding author confirms that ethical considerations were taken into account in conducting this research, and they assert the article's originality with unpublished content. The research adhered to ethical principles rooted in the Declaration of Helsinki. The study protocol, along with the subject information and consent form, underwent review and approval by a local ethics committee, as indicated by document number DNE.151 (1/2/2023), to secure ethical clearance.

This study focused on the development of a plant-based solution for potential future use in treating human endodontic infections. While this study primarily dealt with experimental work on plant extracts and their effects on bacterial gene expression, it is crucial to note that this project aligns with broader ethical and regulatory considerations.

In this context, this study not only adhered to Helsinki guidelines but also obtained confirmation of compliance with the International Union for Conservation of Nature (IUCN) guidelines. These measures ensure the ethical conduct of research and the responsible use of natural resources.

3. RESULTS

3.1. Sub-inhibitory Concentration and Minimum Inhibitory Concentration (MIC)

The investigation into sub-inhibitory concentration and Minimum Inhibitory Concentration (MIC) for various fractions derived from Azadirachta indica yielded compelling results. Each fraction obtained from Azadirachta indica demonstrated notable antimicrobial properties, as evidenced by their ability to inhibit the growth of the target bacteria. Notably, Fraction 3 (Azadirachta indica-ethyl acetate) displayed its Minimal Inhibitory Concentration (MIC) at 30mg/ml, showcasing its effectiveness in inhibiting the growth of the targeted bacteria. On the other end of the spectrum, Fraction 6 (Azadirachta indica-water) exhibited a higher MIC of 50mg/ml, signifying the maximum concentration at which the growth of the target bacteria was significantly inhibited by the antimicrobial properties inherent in this particular fraction. The intricacies of these MIC values, illustrated in Fig. (1), contribute to a comprehensive understanding of the inhibitory capacities of distinct fractions of Azadirachta indica against the target bacteria.

Fig. (1). MIC of different fractions of Azadirachta indica against E. faecalis (ATCC 29,212).
Table 3.
Impact of various azadirachta indica fractions on the expression of the esp gene.
Parameter F-1 F-2 F-3 F-4 F-5 F-6
Normalize change value 0.517632 0.888843 0.239816 0.150726 0.139661 0.959264
Change fold 0.95 0.17 2.06 2.73 2.84 0.06

3.2. Effect of Azadirachtolide Indica on Expression of esp Gene

Table 3 presents the impact of different Azadirachta indica fractions on the expression of the esp gene, revealing valuable insights into the modulation of gene expression levels. The parameters include Normalize Change Values and Change Fold for each fraction (F-1 to F-6). Notably, all fractions exhibited a significant normalized change value, suggesting a notable alteration in gene expression. Moreover, the change fold values provide a quantifiable measure of the fold change in gene expression, with Fraction 5 (F-5) showing the most substantial fold change at 2.84. Thus, Fraction 5 significantly decreased the expression of the target gene.

4. DISCUSSION

Enterococcus faecalis consistently emerges as the predominant or most frequently detected species in oral infections, playing a significant role in various conditions such as marginal periodontitis, infected root canals, and periradicular abscesses [64, 65]. Furthermore, E. faecalis is intricately linked to both primary, secondary, and persistent infections associated with periradicular disease, as highlighted in previous studies [19, 20]. Recognizing the challenges posed by E. faecalis, extensive research has delved into exploring various endodontic medicaments and irrigants aimed at removing or preventing the bacterium from gaining access to the root canal system during treatment [66, 67]. Notably, contemporary approaches have shifted towards exploring natural remedies over conventional bactericidal drugs, as evidenced by a previous work [68]. This paradigm shift underscores the evolving strategies in endodontic treatment, emphasizing the exploration of alternative, nature-based solutions to address the persistent challenges posed by Enterococcus faecalis.

Several studies have been dedicated to exploring the antimicrobial properties of plant-derived or natural products against Enterococcus faecalisand other species [69-72]. For instance, the study conducted by Kadhim et al. [41] delved into the antimicrobial effects of green tea against E. faecalis strains (ATCC 29212), and a study by Sopandani et al. [73] concluded that M. oleifera extract solution at concentrations of 75% and 100% is as effective as 5.25% NaOCl against Enterococcus faecalis. The findings of these investigations led to the conclusion that the plant extract could serve as a viable alternative to sodium hypochlorite and other solutions commonly employed in endodontic irrigation.

In a distinct approach, some studies have focused on determining the impact of extracted plant active substances on the virulence genes or quorum-sensing genes in pathogenic bacteria. Notably, a study in the northern part of Iraq investigated the effects of Liquorice and Azadirachta indica on various genes in E. faecalis [68]. Additionally, phytochemicals have been explored for their potential as antibiofilm agents against the mentioned bacteria. Another study reported that terpenes, phenylpropenes, flavonoids, curcuminoids, and alkaloids were effective in inhibiting the formation and/or eradicating E. faecalis biofilms [74]. This growing body of research underscores the diverse avenues being explored to harness the antimicrobial potential of natural products in the context of Enterococcus faecalis and suggests promising alternatives to traditional endodontic approaches.

The results of the present study elucidate the inhibitory potential of all fractions derived from Azadirachta indica on the (esp) virulence gene. The concentration range within which these fractions demonstrated inhibitory effects on the growth of the target bacteria varied, with (30mg/ml) of (Azadirachta indica-ethyl acetate) representing the lowest concentration inhibiting bacterial growth and (50 mg/ml) of (Azadirachta indica-water) constituting the highest concentration inhibiting bacterial proliferation. Remarkably, these findings align with prior research, which concluded that plant extracts exhibit inhibitory effects on the expression of virulence and biofilm genes [68, 75, 76]. It is noteworthy that this study stands as the first of its kind to specifically assess the impact of the esp gene in E. faecalis treated with various fractions of Azadirachta indica. In contrast, previous investigations focused on determining the expression of the same gene after treatment with juglone derivatives [77]. This novel contribution expands our understanding of the intricate molecular interactions between Azadirachta indica fractions and the virulence genes of E. faecalis, shedding light on potential paths for targeted therapeutic interventions in endodontic applications.

CONCLUSION

In conclusion, every fraction derived from Azadirachta indica demonstrated antimicrobial properties, with Fraction 3 (Azadirachta indica-ethyl acetate) exhibiting the lowest Minimum Inhibitory Concentration (MIC) at 30mg/ml, and Fraction 6 (Azadirachta indica-water) displaying the highest MIC at 50mg/ml against E. faecalis (ATCC 29,212). Real-time quantitative polymerase chain reaction (RT-qPCR) analysis revealed a consistent decrease in gene expression across all fractions. Fraction 5 showed the most significant fold change, suggesting a potential decrease in (esp) gene expression, which could be considered an alternative to classical irrigants.

LIST OF ABBREVIATIONS

Esp Gene = Enterococcal Surface Protein
A. Indica = Azadirachta Indica
E. Faecalis = Enterococcus faecalis
cDNA = Complementary DNA

ETHICAL STATEMENT

The study protocol, along with the subject information and consent form, underwent review and approval by a local ethics committee, as indicated by document number DNE.151 (1/2/2023), to secure ethical clearance.

This study not only adhered to Helsinki guidelines but also obtained confirmation of compliance with the International Union for Conservation of Nature (IUCN) guidelines.

CONSENT FOR PUBLICATION

Not applicable.

AVAILABILITY OF DATA AND MATERIAL

The authors confirm that the data supporting the findings of this research are available within the article.

FUNDING

None.

CONFLICT OF INTEREST

The author declared no conflict of interest, financial or otherwise.

ACKNOWLEDGEMENTS

Declared none.

REFERENCES

1
Rôças IN, Ricucci D, Siqueira JF Jr. Causes of endodontic treatment failure. Treatment of Endodontic Infections.Available from: https://pocketdentistry.com/causes-of-endodontic-treatment-failure/
2
Gulabivala K, Ng YL. Factors that affect the outcomes of root canal treatment and retreatment: A reframing of the principles. Int Endod J 2023; 56(S2)(Suppl. 2): 82-115.
3
Khan AM, Sindi AM, Alogaly JA, Ashour MS. Factors affecting the success of endodontic treatment (surgical or nonsurgical): A brief. Int J Med Dev Ctries 2019; 3: 730-3.
4
Siqueira JF Jr, Rôc̦as IN. Treatment of endodontic infections 2022; 1-576.
5
Segura-Egea JJ, Cabanillas-Balsera D, Martín-González J, Cintra LTA. Impact of systemic health on treatment outcomes in endodontics. Int Endod J 2023; 56(S2)(Suppl. 2): 219-35.
6
Bhardwaj SB. Enterococci: An important nosocomial pathogen. Pathogenic bacteria 2019; 1-246.
7
Arora S, Saquib SA, Algarni YA, et al. Synergistic effect of plant extracts on endodontic pathogens isolated from teeth with root canal treatment failure: An in vitro study. Antibiotics 2021; 10(5): 552.
8
Portela CAF, Smart KF, Tumanov S, Cook GM, Villas-Bôas SG. Global metabolic response of Enterococcus faecalis to oxygen. J Bacteriol 2014; 196(11): 2012-22.
9
García-Solache M, Rice LB. The Enterococcus: A model of adaptability to its environment. Clin Microbiol Rev 2019; 32(2): e00058-18.
10
Castellani F, Ghidini V, Tafi MC, Boaretti M, Lleo MM. Fate of pathogenic bacteria in microcosms mimicking human body sites. Microb Ecol 2013; 66(1): 224-31.
11
Alshanta OAM. Candida albicans and Enterococcus faecalis interkingdom interaction: implications for management of endodontic infections 2022; 1-6.
12
Yusuf-Omoloye NA, Adeyemi FM, Sule WF, Yusuf W, Ajigbewu OH, Adegbite-Badmus MK, et al. Culture-dependent and molecular characterization of vancomycin-resistant enterococci from clinical, food, and water samples across Osun State, Southwest Nigeria. Sci Am 2023; 21: e01813.
13
Zoletti GO, Pereira EM, Schuenck RP, Teixeira LM, Siqueira JF Jr, dos Santos KRN. Characterization of virulence factors and clonal diversity of Enterococcus faecalis isolates from treated dental root canals. Res Microbiol 2011; 162(2): 151-8.
14
Kangabam N, Subbiya A, Geethapriya N, Padmavathy K, Mahalakshmi K, Megha R. Efficacy of herbal extracts against Enterococcus faecalis on a dentinal biofilm. Oper Dent Endod 2019; 4: 22-6.
15
Lucchese A, Bertacci A, Chersoni S, Portelli M. Primary enamel permeability: A SEM evaluation in vivo. Eur J Paediatr Dent 2012; 13(3): 231-5.
16
Ørstavik D. Endodontic treatment of apical periodontitis 2019; 313-44.
17
Francisco PA. Fagundes PIdG, Lemes-Junior JC, Lima AR, Passini MRZ, Gomes BP. Pathogenic potential of Enterococcus faecalis strains isolated from root canals after unsuccessful endodontic treatment. Clin Oral Investig 2021; 5: 1-9.
18
Varghese RM. Cumulative factors determining endodontic operative pain and persistent apical periodontitis following nonsurgical root canal treatment in permanent teeth : A comprehensive literature review. Schol J Dent Sci 2023; 10(7): 145-70.
19
Akbari Aghdam M, Soroush Barhaghi MH, Aghazadeh M, et al. Virulence genes in biofilm producer Enterococcus faecalis isolates from root canal infections. Cell Mol Biol 2017; 63(5): 55-9.
20
Kumar D, Singh KK, Kumar P, et al. Association of specific microorganisms with endodontic signs and symptoms. A comparative study. J Family Med Prim Care 2020; 9(8): 3965-9.
21
Albashaireh KZ. Microbial interkingdom interaction in endodontic biofilms and the quest for novel antimicrobial treatments 2022; 1-12.
22
Karayasheva D, Radeva E. Importance of Enterococci (Enterococcus faecalis) for dental medicine–microbiological characterization, prevalence and resistance. Int J Sci Res 2017; 6: 1970-3.
23
Ran S, Liu B, Jiang W, Sun Z, Liang J. Transcriptome analysis of Enterococcus faecalis in response to alkaline stress. Front Microbiol 2015; 6: 795.
24
Bhattacharya S, Mukherjee J, Discovery AD. Microbial infections and virulence factors. Model Organisms for Microbial Pathogenesis, Biofilm Formation 2020; 1-18.
25
Rahman IR, Sanchez A, Tang W, van der Donk WA. Structure–activity relationships of the enterococcal cytolysin. ACS Infect Dis 2021; 7(8): 2445-54.
26
Rana M, Jain V, Kaur P, Jalan P, Kapadia JM, Shaikh I. Assessment of impact of various root canal irrigants on the adherence of the gelatinase-producing and the gelatinase-deficient E. faecalis strains to dentin. J Contemp Dent Pract 2019; 20(1): 46-50.
27
Yoki H, Sadaomi S, Norimasa T, Takeshi I, Hiroshi M. Analysis of gene expression profiles of Enterococcus faecalis induced by type I collagen. World J Adv Res Rev 2022; 13(1): 129-39.
28
Asmah N. Molecular aspects of Enterococcus faecalis virulence. J Syiah Kuala DentSoc 2022; 5(2): 89-94.
29
Najafi K, Ganbarov K, Gholizadeh P, et al. Oral cavity infection by Enterococcus faecalis: virulence factors and pathogenesis. Rev Med Microbiol 2020; 31(2): 51-60.
30
Șchiopu P, Toc DA, Colosi IA, et al. An overview of the factors involved in biofilm production by the enterococcus genus. Int J Mol Sci 2023; 24(14): 11577.
31
Ch’ng JH, Chong KKL, Lam LN, Wong JJ, Kline KA. Biofilm-associated infection by enterococci. Nat Rev Microbiol 2019; 17(2): 82-94.
32
Taglialegna A, Matilla-Cuenca L, Dorado-Morales P, Navarro S, Ventura S, Garnett JA, et al. The biofilm-associated surface protein Esp of Enterococcus faecalis forms amyloid-like fibers. npj Biofilms Microbiomes 2020; 6(1): 15.
33
Abusrewil S, Alshanta OA, Albashaireh K, et al. Detection, treatment and prevention of endodontic biofilm infections: what’s new in 2020? Crit Rev Microbiol 2020; 46(2): 194-212.
34
Spiegelman L, Bahn-Suh A, Montaño ET, et al. Strengthening of enterococcal biofilms by Esp. PLoS Pathog 2022; 18(9): e1010829.
35
Nascimento GG, Rabello DGD, Corazza BJM, Gomes APM, Silva EG, Martinho FC. Comparison of the effectiveness of single and multiple-sessions disinfection protocols against endotoxins in root canal infections: Systematic review and meta-analysis. Sci Rep 2021; 11(1): 1226.
36
da Silva Magalhães K, Kuerten Gil AC, Goulart TS, et al. Efficacy of disinfection procedures performed prior to regenerative endodontic therapy: An integrative review. Aust Endod J 2023; 49(2): 418-27.
37
Ali A, Bhosale A, Pawar S, Kakti A, Bichpuriya A, Agwan MA. Current trends in root canal irrigation. Cureus 2022; 14(5): e24833.
38
Basrani B, Haapasalo M. Update on endodontic irrigating solutions. Endod Topics 2012; 27(1): 74-102.
39
Saatchi M, Shokraneh A, Navaei H, Maracy MR, Shojaei H. Antibacterial effect of calcium hydroxide combined with chlorhexidine on Enterococcus faecalis: A systematic review and meta-analysis. J Appl Oral Sci 2014; 22(5): 356-65.
40
Ruksakiet K, Hanák L, Farkas N, Hegyi P, Sadaeng W, Czumbel LM, et al. Antimicrobial efficacy of chlorhexidine and sodium hypochlorite in root canal disinfection: A systematic review and meta-analysis of randomized controlled trials. J Endod 2020; 46(8): 1032-41.
41
Kadhim EM, Amin BK. The antibacterial effect of green tea on Enterococcus faecalis, Iraq. Medical J Babylon 2022; 19(4): 676.
42
Emil J, Paulaian B, John B, Raja J, Mathew J, Mathew J. Viability and antibacterial efficacy of four root canal disinfection techniques evaluated using confocal laser scanning microscopy. J Conserv Dent 2014; 17(5): 444-8.
43
Segura-Egea JJ, Gould K, Hakan Şen B, et al. European society of endodontology position statement: The use of antibiotics in endodontics. Int Endod J 2018; 51(1): 20-5.
44
Zanjir M, Sgro A, Lighvan NL, Yarascavitch C, Shah PS, da Costa BR, et al. Efficacy and safety of postoperative medications in reducing pain after nonsurgical endodontic treatment: A systematic review and network meta-analysis. J Endod 2020; 46(10): 1387-402.
45
Nagendrababu V, Vinothkumar TS, El-Karim I, et al. Dental patient-reported outcomes in endodontics a narrative review. J Evid Based Dent Pract 2023; 23(1): 101805.
46
Raducka M, Piszko A, Piszko PJ, et al. Narrative review on methods of activating irrigation liquids for root canal treatment. Appl Sci 2023; 13(13): 7733.
47
Al Qarni FM, ElFasakhany FM, Kenawi LM, Moustafa AM. Antimicrobial activity of Azadirachta indica (neem) and Salvadora persica (miswak) extracts as endodontic irrigants. Endodontic Practice Today 2019; 13(3): 1-6.
48
Agnihotri A, Jhamb S, Shrama U, Rohtagi S. Azadirachta indica A. juss, Morinda citrifolia L. and Triphala as herbal endodontic irrigants: A scoping review. Ayu 2020; 41(3): 148-58.
49
Hosny NS, El Khodary SA, El Boghdadi RM, Shaker OG. Effect of Neem (Azadirachta indica) versus 2.5% sodium hypochlorite as root canal irrigants on the intensity of post‐operative pain and the amount of endotoxins in mandibular molars with necrotic pulps: A randomized controlled trial. Int Endod J 2021; 54(9): 1434-47.
50
Maithani A, Parcha V, Pant G, Dhulia I, Kumar D. Azadirachta indica (neem) leaf: A review. J Pharm Res 2011; 4(6): 1824-7.
51
Oluwasina OO, Idris SO, Ogidi CO, Igbe FO. Production of herbal toothpaste: Physical, organoleptic, phyto-compound, and antimicrobial properties. Heliyon 2023; 9(3): e13892.
52
Modi CM, Patel HB, Patel UD, et al. Anti-inflammatory and antioxidant potential of Azadirachta indica flower. J Vet Pharmacol Toxicol 2021; 20(1): 13-7.
53
Akin-Osanaiya B, Nok A, Ibrahim S, et al. Antimalarial effect of neem leaf and neem stem bark extracts on Plasmodium berghei infected in the pathology and treatment of malaria. Int J ResBiochemBiophys 2013; 3(1): 7-14.
54
Vinod V, Tiwari PK, Meshram GP. Evaluation of mutagenic and antimutagenic activities of neem (Azadirachta indica) seed oil in the in vitroAmes Salmonella/microsome assay and in vivo mouse bone marrow micronucleus test. J Ethnopharmacol 2011; 134(3): 931-7.
55
Paul R, Prasad M, Sah NK. Anticancer biology of Azadirachta indica L (neem): A mini review. Cancer Biol Ther 2011; 12(6): 467-76.
56
Agrawal S, Bablani Popli D, Sircar K, Chowdhry A. A review of the anticancer activity of Azadirachta indica (Neem) in oral cancer. J Oral Biol Craniofac Res 2020; 10(2): 206-9.
57
Uzzaman S. Pharmacological activities of neem (Azadirachta indica): A review. Int J Pharmacog Life Sci 2020; 1(1): 38-41.
58
Pingali U, Ali MA, Gundagani S, Nutalapati C. Evaluation of the effect of an aqueous extract of Azadirachta indica (Neem) leaves and twigs on glycemic control, endothelial dysfunction and systemic inflammation in subjects with type 2 diabetes mellitus–A randomized, double-blind, placebo-controlled clinical study. Diabetes Metab Syndr Obes 2020; 13: 4401-12.
59
Farzana S, Saha SP, Sultana N, Khan MI. Gastroprotective Effect of Azadirachta indica Leaves (Neem) extract on aspirin induced gastric ulcer in rats. Delta Med College J 2020; 7(2): 61-5.
60
Gautam S, Thakur M, Aggarwal M, Vatsa E. Azadirachta indica: A review as a potent anti-diabetic drug. Sci Aliment Agrícola 2021; 1(10): 1-6.
61
Patil SM, Shirahatti PS, Ramu R. Azadirachta indica A. Juss (neem) against diabetes mellitus: A critical review on its phytochemistry, pharmacology, and toxicology. J Pharm Pharmacol 2022; 74(5): 681-710.
62
Mohammed HA, Al Fadhil AO. Antibacterial activity of Azadirachta indica (Neem) leaf extract against bacterial pathogens in Sudan. Afr J Med Sci 2017; 3: 246-2512.
63
Moliz MTA, Luque CMF, Rodríguez MPG, Escobar EN, García PB. Antimicrobial activity and Enterococcus faecalis biofilm formation on chlorhexidine varnishes. medicina oral 2012; 17(9): 9.
64
Alghamdi F, Shakir M. The influence of Enterococcus faecalis as a dental root canal pathogen on endodontic treatment: A systematic review. Cureus 2020; 12(3): e7257.
65
Elahe T, Zahra H, Mostafa A. The current novel drug delivery system (natural and chemical composites) in dental infections for antibiotics resistance: A narrative review. Cell Mol Biol 2022; 68(10): 141-60.
66
Azad A, Rostamifar S, Modaresi F, Bazrafkan A, Rezaie Z. Assessment of the antibacterial effects of bismuth nanoparticles against Enterococcus faecalis. Biomed Res Int 2020; 2020: 5465439.
67
Capuano N, Amato A, Dell’Annunziata F, et al. Nanoparticles and their antibacterial application in endodontics. Antibiotics 2023; 12(12): 1690.
68
Kadhim E, Amin B. amin bkjpcb. Effect of liquorice and azadirachta indica extracts on the expression of virulence genes of Enterococcus faecalis. Plant Cell Biotechnol Mol Biol 2021; 5: 419-25.
69
Bardají DKR, Reis EB, Medeiros TCT, Lucarini R, Crotti AEM, Martins CHG. Antibacterial activity of commercially available plant-derived essential oils against oral pathogenic bacteria. Nat Prod Res 2016; 30(10): 1178-81.
70
Barbieri R, Coppo E, Marchese A, et al. Phytochemicals for human disease: An update on plant-derived compounds antibacterial activity. Microbiol Res 2017; 196: 44-68.
71
Yang SK, Low LY, Yap PSX, et al. Plant-derived antimicrobials: Insights into mitigation of antimicrobial resistance. Rec Nat Prod 2018; 12(4): 295-396.
72
Woo S, Marquez L, Crandall WJ, Risener CJ, Quave CL. Recent advances in the discovery of plant-derived antimicrobial natural products to combat antimicrobial resistant pathogens: insights from 2018–2022. Nat Prod Rep 2023; 40(7): 1271-90.
73
Sopandani P, Iskandar B, Ariwibowo T, Djamil M. Antibacterial effects of moringa oleifera leaf extract against Enterococcus faecalisin vitrio. ScientDent J 2020; 4(1): 16-20.
74
Ali IAA, Neelakantan P. Antibiofilm activity of phytochemicals against Enterococcus faecalis : A literature review. Phytother Res 2022; 36(7): 2824-38.
75
Yousef A, Abu-Elghait M, Barghoth MG, Elazzazy AM, Desouky SE. Fighting multidrug-resistant Enterococcus faecalisvia interfering with virulence factors using green synthesized nanoparticles. Microb Pathog 2022; 173(Pt A): 105842.
76
Montanari C, Barbieri F, Lorenzini S, et al. Survival, growth, and biogenic amine production of Enterococcus faecium FC12 in response to extracts and essential oils of Rubus fruticosus and Juniperus oxycedrus. Front Nutr 2023; 9: 1092172.
77
Niaz F, Faheem M, Khattak M, Khawaja IA, Ahn M-J, Sarker U, et al. Antibacterial and antibiofilm activity of juglone derivatives against Enterococcus faecalis : An In Silico and In Vitro Approach. BioMed Res Int 2022; 2022: 6197375.